New onset geriatric epilepsy
A randomized study of gabapentin, lamotrigine, and carbamazepine
Abstract
Objective: To determine the relative tolerability and efficacy of two newer antiepileptic drugs, lamotrigine (LTG) and gabapentin (GBP), as compared to carbamazepine (CBZ) in older patients with epilepsy.
Methods: This was an 18-center, randomized, double-blind, double dummy, parallel study of 593 elderly subjects with newly diagnosed seizures. Patients were randomly assigned to one of three treatment groups: GBP 1,500 mg/day, LTG 150 mg/day, CBZ 600 mg/day. The primary outcome measure was retention in trial for 12 months.
Results: Mean age was 72 years. The most common etiology was cerebral infarction. Patients had multiple medical conditions and took an average of seven comedications. Mean plasma levels at 6 weeks were as follows: GBP 8.67 ± 4.83 μg/mL, LTG 2.87 ± 1.60 μg/mL, CBZ 6.79 ± 2.92 μg/mL. They remained stable throughout the trial. Early terminations: LTG 44.2%, GBP 51%, CBZ 64.5% (p = 0.0002). Significant paired comparisons: LTG vs CBZ: p < 0.0001; GBP vs CBZ: p = 0.008. Terminations for adverse events: LTG 12.1%, GBP 21.6%, CBZ 31% (p = 0.001). Significant paired comparisons: LTG vs CBZ: p < 0.0001; LTG vs GBP: p = 0.015. There were no significant differences in seizure free rate at 12 months.
Conclusions: The main limiting factor in patient retention was adverse drug reactions. Patients taking lamotrigine (LTG) or gabapentin (GBP) did better than those taking carbamazepine. Seizure control was similar among groups. LTG and GBP should be considered as initial therapy for older patients with newly diagnosed seizures.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
References
1.
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935–1984. Epilepsia 1993;34:453–458.
2.
Hauser WA. Epidemiology of seizures and epilepsy in the elderly. In: Rowan AJ, Ramsay RE, eds. Seizures and epilepsy in the elderly. New York: Butterworth-Heinemann, 1997;7–20.
3.
Vestal RE, Cusack BJ. Pharmacology and aging. In: Schneider EL, Rowe JW, eds. Handbook of the biology of aging. San Diego: Academic Press, 1990;349–383.
4.
Rowe JW, Andres RA, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in man: a cross sectional and longitudinal study. J Gerontol 1976;31:155–163.
5.
Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow. The influence of drug metabolism in the elderly. Clin Pharmacokinet 1988;15:287–294.
6.
Salzman C, Shader RI, Greenblatt DJ, Harmatz JS. Long versus short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. Arch Gen Psychiatry 1983;40:293–297.
7.
Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriat Med 1990;6:269–283.
8.
The US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res 1994;18:67–73.
9.
Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152–176.
10.
Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81–87.
11.
Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145–151.
12.
Mattson RH, Cramer JA, Collins JF, DVA Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765–771.
13.
Ramsay RE, Pryor FM. Gabapentin: adverse effects. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs. Philadelphia: Lippincott Williams & Wilkins, 2002;354–359.
14.
Leppik IE, Cloyd JC. Epilepsy in the elderly. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs. Philadelphia: Lippincott Williams & Wilkins, 2002;149–158.
15.
So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350–355.
16.
Heuts-van Raak L, Lodder J, Kessels F. Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 1996;5:185–194.
17.
Luehdorf K, Jensen LK, Plesner AM. Etiology of seizures in the elderly. Epilepsia 1986;27:458–463.
18.
Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol 1990;237:166–170.
19.
Paolucci S, Silvestri G, Lubich S, Pratesi L, Traballesi M, Gigli GL. Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia 1997;38:266–270.
20.
Hauser WA, Anderson VE, Loewenson RB, McRoberts SM. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982;307:522–528.
Information & Authors
Information
Published In
Copyright
© 2005.
Publication History
Published online: May 11, 2005
Published in print: June 14, 2005
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Role of α-amino-3‑hydroxy-5-methyl-4-isoxazolepropionic acid receptors and the antagonist perampanel in geriatric epilepsy and status epilepticus, Archives of Gerontology and Geriatrics, 128, (105605), (2025).https://doi.org/10.1016/j.archger.2024.105605
- Running Out of Breath: The Diminishing Role of Gabapentinoids in Epilepsy, Epilepsy Currents, 24, 4, (265-267), (2024).https://doi.org/10.1177/15357597241253505
- Trends, prescribing patterns, and determinants of initial antiepileptic drug treatment in older epileptic patients, International Journal of Pharmacy Practice, (2024).https://doi.org/10.1093/ijpp/riae055
- Overview of acute seizure management in US nursing homes, Epilepsy & Behavior, 158, (109913), (2024).https://doi.org/10.1016/j.yebeh.2024.109913
- Efficacy and safety of Perampanel in the treatment of post stroke epilepsy: A multicenter, real-world study, Heliyon, 10, 5, (e26376), (2024).https://doi.org/10.1016/j.heliyon.2024.e26376
- Geriatric Emergency Medication Safety Recommendations (GEMS-Rx): Modified Delphi Development of a High-Risk Prescription List for Older Emergency Department Patients, Annals of Emergency Medicine, 84, 3, (274-284), (2024).https://doi.org/10.1016/j.annemergmed.2024.01.033
- Serum perampanel levels in patients with seizures are not affected by hemodialysis, Epilepsia Open, 9, 4, (1597-1603), (2024).https://doi.org/10.1002/epi4.12996
- Management of elderly-onset epilepsy: A narrative review, Epilepsy & Seizure, 15, 1, (104-116), (2023).https://doi.org/10.3805/eands.15.104
- Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence, International Journal of Molecular Sciences, 24, 16, (12639), (2023).https://doi.org/10.3390/ijms241612639
- Gabapentin monotherapy for epilepsy: A review, International Journal of Risk & Safety in Medicine, 34, 3, (243-286), (2023).https://doi.org/10.3233/JRS-235001
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.